Israeli Oramed Pharmaceutical Announces Israeli Oral Coronavirus Vaccine Oravax Is 'Coming' to Southeast Asia. This is reported by The Jerusalem Post.
Oravax Medical has signed a cooperation agreement with Vietnam-based Tan Thanh Holdings Investment, which will tentatively purchase 10 million doses of the vaccine.
The agreement allows Tan Thanh Holdings Investment to sell Oravax vaccine throughout the Association of Southeast Asian Nations (ASEAN), which includes Vietnam, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore and Thailand.
< br /> “This pre-purchase of our oral COVID-19 vaccine in development represents an important milestone for Oravax Medical and another step forward in our long-term strategy,” said Nadav Kidron, Oramed CEO and Chairman of Oravax.